D
Devasena Anantharaman
Researcher at Rajiv Gandhi Centre for Biotechnology
Publications - 45
Citations - 1818
Devasena Anantharaman is an academic researcher from Rajiv Gandhi Centre for Biotechnology. The author has contributed to research in topics: Cancer & Head and neck cancer. The author has an hindex of 21, co-authored 42 publications receiving 1371 citations. Previous affiliations of Devasena Anantharaman include International Agency for Research on Cancer & Tata Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator
TL;DR: The finding that GSTM1 null genotype is a risk factor to OSCC among Indian tobacco habits; GSTT1null genotype emerged as a protective factor is supported.
Journal ArticleDOI
Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer.
Devasena Anantharaman,Manuela Marron,Pagona Lagiou,Evangelia Samoli,Wolfgang Ahrens,Hermann Pohlabeln,Alena Slamova,Miriam Schejbalova,Franco Merletti,Lorenzo Richiardi,Kristina Kjærheim,Xavier Castellsagué,Antonio Agudo,Renato Talamini,Luigi Barzan,Tatiana V. Macfarlane,Martin Tickle,Lorenzo Simonato,Cristina Canova,Cristina Canova,David I. Conway,David I. Conway,Patricia A. McKinney,Patricia A. McKinney,Peter Thomson,Ariana Znaor,Claire M. Healy,B. E. McCartan,Mia Hashibe,Paul Brennan,Gary J. Macfarlane +30 more
TL;DR: While the majority of the UADT cancers in Europe are due to tobacco or the joint effect of tobacco and alcohol, the results support a significant role for other risk factors in particular, for oral and oropharyngeal cancers and also for UADt cancers in southern and western Europe.
Journal ArticleDOI
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
Corina Lesseur,Brenda Diergaarde,Andrew F. Olshan,Victor Wünsch-Filho,Andy R Ness,Andy R Ness,Geoffrey Liu,Martin Lacko,José Eluf-Neto,Silvia Franceschi,Pagona Lagiou,Gary J. Macfarlane,Lorenzo Richiardi,Stefania Boccia,Jerry Polesel,Kristina Kjærheim,David Zaridze,Mattias Johansson,Ana Maria Menezes,Maria Paula Curado,Max Robinson,Wolfgang Ahrens,Cristina Canova,Ariana Znaor,Xavier Castellsagué,David I. Conway,Ivana Holcatova,Dana Mates,Marta Vilensky,Claire M. Healy,Neonila Szeszenia-Dąbrowska,Eleonora Fabianova,Jolanta Lissowska,Jennifer R. Grandis,Mark C. Weissler,Eloiza H. Tajara,Fábio Daumas Nunes,Marcos Brasilino de Carvalho,Steve Thomas,Rayjean J. Hung,Wilbert H.M. Peters,Rolando Herrero,Gabriella Cadoni,H. Bas Bueno-de-Mesquita,H. Bas Bueno-de-Mesquita,Annika Steffen,Antonio Agudo,Oxana Shangina,Xiangjun Xiao,Valerie Gaborieau,Amelie Chabrier,Devasena Anantharaman,Paolo Boffetta,Christopher I. Amos,James McKay,Paul Brennan +55 more
TL;DR: Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301–HLA-DQA1*0103–HLa-DQB1*0603.
Journal ArticleDOI
Human Papillomavirus Infections and Upper Aero-Digestive Tract Cancers: The ARCAGE Study
Devasena Anantharaman,Tarik Gheit,Tim Waterboer,Tim Waterboer,Behnoush Abedi-Ardekani,Christine Carreira,Sandrine McKay-Chopin,Valerie Gaborieau,Manuela Marron,Pagona Lagiou,Wolfgang Ahrens,Wolfgang Ahrens,Ivana Holcatova,Franco Merletti,Kristina Kjærheim,Renato Talamini,Lorenzo Simonato,Xavier Castellsagué,Tatiana V. Macfarlane,Anne Marie Biggs,Nalin Thakker,Ariana Znaor,Peter Thomson,Cristina Canova,David I. Conway,Claire M. Healy,Massimo Tommasino,Michael Pawlita,Michael Pawlita,Paul Brennan +29 more
TL;DR: An important role for HPV16 infection in oropharyngeal cancer is confirmed and continuing efforts are needed to consider both HPV serology and p16 staining as biomarkers relevant to the etiology and natural history of HPV16-related oropharygeal tumors.
Journal ArticleDOI
Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status.
Eugenie Du,Angela L. Mazul,Doug Farquhar,Paul Brennan,Devasena Anantharaman,Devasena Anantharaman,Behnoush Abedi-Ardekani,Mark C. Weissler,David N. Hayes,Andrew F. Olshan,Jose P. Zevallos,Jose P. Zevallos +11 more
TL;DR: Ten‐year overall survival rates for cases to population‐based controls in head and neck squamous cell carcinoma are compared to population-based controls.